JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on April 18, 2006; DOI: 10.1124/jpet.106.101691


0022-3565/06/3181-434-443$20.00
JPET 318:434-443, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.101691v1
318/1/434    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogata, J.
Right arrow Articles by Harris, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogata, J.
Right arrow Articles by Harris, R. A.

NEUROPHARMACOLOGY

Effects of Anesthetics on Mutant N-Methyl-D-Aspartate Receptors Expressed in Xenopus Oocytes

Junichi Ogata1, Munehiro Shiraishi1, Tsunehisa Namba, C. Thetford Smothers, John J. Woodward, and R. Adron Harris

Waggoner Center for Alcohol and Addiction Research and the Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas (J.O., M.S., R.A.H.); Department of Anesthesia, Kyoto University Hospital, Kyoto, Japan (T.N.); and Department of Physiology and Neuroscience, Medical University of South Carolina, Charleston, South Carolina (C.T.S., J.J.W.).

Alcohols, inhaled anesthetics, and some injectable anesthetics inhibit the function of N-methyl-D-aspartate (NMDA) receptors, but the mechanisms responsible for this inhibition are not fully understood. Recently, it was shown that ethanol inhibition of NMDA receptors was reduced by mutation of residues in the transmembrane (TM) segment 3 of the NR1 subunit (F639A) or in TM4 of the NR2A subunit (A825W), suggesting putative ethanol binding sites. We hypothesized that the actions of other anesthetics might also require these amino acids and evaluated the effects of anesthetics on the NMDA receptors expressed in Xenopus oocytes with two-electrode voltage-clamp recording. Effects of hexanol, octanol, isoflurane, halothane, chloroform, cyclopropane, 1-chloro-1,2,2-trifluorocyclobutane, and xenon were reduced or eliminated in the mutant NMDA receptors, whereas the inhibitory effects of nitrous oxide, ketamine, and benzene were not affected by these mutations. Rapid applications of glutamate and glycine by a T-tube device provided activation time constants, which suggested different properties of ketamine and isoflurane inhibition. Thus, amino acids in TM3 and TM4 are important for the actions of many anesthetics, but nitrous oxide, benzene, and ketamine seem to have distinct mechanisms for inhibition of the NMDA receptors.


Received January 20, 2006; accepted April 11, 2006.

Address correspondence to: Dr. R. Adron Harris, University of Texas, Waggoner Center for Alcohol and Addiction Research, 1 University Station A4800, Austin, TX 78712-0159. E-mail: harris{at}mail.utexas.edu




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
J. M. Sonner
A Hypothesis on the Origin and Evolution of the Response to Inhaled Anesthetics
Anesth. Analg., September 1, 2008; 107(3): 849 - 854.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. Yang and J. M. Sonner
Anesthetic-Like Modulation of Receptor Function by Surfactants: A Test of the Interfacial Theory of Anesthesia
Anesth. Analg., September 1, 2008; 107(3): 868 - 874.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. Jenkins, I. A. Lobo, D. Gong, J. R. Trudell, K. Solt, R. A. Harris, and E. I. Eger II
General Anesthetics Have Additive Actions on Three Ligand Gated Ion Channels
Anesth. Analg., August 1, 2008; 107(2): 486 - 493.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
H. U. Weigt, O. Adolph, M. Georgieff, E. M. Georgieff, and K. J. Fohr
Evidence That Xenon Does Not Produce Open Channel Blockade of the NMDA Receptor
J Neurophysiol, April 1, 2008; 99(4): 1983 - 1987.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. Yang and J. M. Sonner
The Anesthetic-Like Effects of Diverse Compounds on Wild-Type and Mutant {gamma}-Aminobutyric Acid Type A and Glycine Receptors
Anesth. Analg., March 1, 2008; 106(3): 838 - 845.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
E. W. Kelly, K. Solt, and D. E. Raines
Volatile Aromatic Anesthetics Variably Impact Human {gamma}-Aminobutyric Acid Type A Receptor Function
Anesth. Analg., November 1, 2007; 105(5): 1287 - 1292.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
L. Yang, J. Zhao, P. S. Milutinovic, R. J. Brosnan, E. I. Eger II, and J. M. Sonner
Anesthetic Properties of the Ketone Bodies {beta}-Hydroxybutyric Acid and Acetone
Anesth. Analg., September 1, 2007; 105(3): 673 - 679.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. T. Smothers and J. J. Woodward
Pharmacological Characterization of Glycine-Activated Currents in HEK 293 Cells Expressing N-Methyl-D-aspartate NR1 and NR3 Subunits
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 739 - 748.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. S. Milutinovic, L. Yang, R. S. Cantor, E. I. Eger II, and J. M. Sonner
Anesthetic-Like Modulation of a {gamma}-Aminobutyric Acid Type A, Strychnine-Sensitive Glycine, and N-Methyl-d-Aspartate Receptors by Coreleased Neurotransmitters
Anesth. Analg., August 1, 2007; 105(2): 386 - 392.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.